IRIS
1.5 Abstract in rivista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.474
NA - Nord America 10.011
EU - Europa 4.096
SA - Sud America 1.379
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 94
Totale 35.355
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.005
US - Stati Uniti d'America 9.600
CN - Cina 2.294
IT - Italia 2.034
HK - Hong Kong 1.309
BR - Brasile 978
GB - Regno Unito 642
VN - Vietnam 553
FR - Francia 495
BD - Bangladesh 330
IN - India 307
DE - Germania 266
CA - Canada 216
AR - Argentina 144
NL - Olanda 112
ID - Indonesia 108
TR - Turchia 98
MX - Messico 92
EC - Ecuador 76
CO - Colombia 74
AU - Australia 66
CZ - Repubblica Ceca 57
EE - Estonia 57
FI - Finlandia 57
PK - Pakistan 53
JP - Giappone 51
UA - Ucraina 51
PL - Polonia 45
SA - Arabia Saudita 45
ES - Italia 43
ZA - Sudafrica 43
MY - Malesia 41
PH - Filippine 40
IQ - Iraq 39
EG - Egitto 32
CL - Cile 31
RU - Federazione Russa 29
JM - Giamaica 27
VE - Venezuela 27
PY - Paraguay 25
MD - Moldavia 23
NZ - Nuova Zelanda 22
AE - Emirati Arabi Uniti 21
IE - Irlanda 20
SE - Svezia 20
TW - Taiwan 20
AT - Austria 19
NP - Nepal 17
ET - Etiopia 16
MA - Marocco 16
TN - Tunisia 16
DO - Repubblica Dominicana 14
TH - Thailandia 14
CH - Svizzera 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
LT - Lituania 12
UZ - Uzbekistan 12
HN - Honduras 11
IR - Iran 11
UY - Uruguay 11
KE - Kenya 10
KW - Kuwait 10
DK - Danimarca 9
KR - Corea 9
OM - Oman 9
PT - Portogallo 9
BE - Belgio 8
CR - Costa Rica 8
GH - Ghana 8
HU - Ungheria 8
NO - Norvegia 8
RO - Romania 8
AL - Albania 7
DZ - Algeria 7
GT - Guatemala 7
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
NI - Nicaragua 6
PR - Porto Rico 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
LB - Libano 5
LY - Libia 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BG - Bulgaria 4
BH - Bahrain 4
KH - Cambogia 4
LK - Sri Lanka 4
MK - Macedonia 4
PS - Palestinian Territory 4
AO - Angola 3
CI - Costa d'Avorio 3
Totale 35.168
Salva come PNG Salva come JPEG
Città #
San Jose 2.797
Singapore 1.771
Ashburn 1.666
Rome 1.415
Hong Kong 1.285
Hefei 986
Council Bluffs 690
Dallas 690
Boardman 583
Columbus 500
London 464
Beijing 452
Lauterbourg 432
Shanghai 342
Ho Chi Minh City 209
Los Angeles 192
New York 160
Santa Clara 138
Hanoi 132
San Francisco 125
Pune 114
Phoenix 97
São Paulo 95
West Jordan 90
Milan 80
Munich 70
Amsterdam 69
Toronto 62
Washington 62
Chicago 54
Seattle 50
Brooklyn 45
Mexico City 42
Brno 41
Naples 39
Warsaw 37
Buffalo 36
Sona 36
Montreal 35
Turku 35
Las Vegas 34
Tokyo 33
Frankfurt am Main 30
Rio de Janeiro 30
Quito 29
Chennai 25
Atlanta 24
Guayaquil 24
Haiphong 24
Riyadh 23
Brasília 22
Helsinki 22
Kuala Lumpur 22
Melbourne 22
Jakarta 21
Da Nang 20
Manchester 19
Orem 19
Canberra 18
Charlotte 18
Hanover 18
Nuremberg 18
Paris 18
Bogotá 17
Boston 17
Buenos Aires 17
Florence 17
Istanbul 17
New Delhi 17
Baghdad 16
Jeddah 16
Johannesburg 16
Bologna 15
Jacksonville 15
Philadelphia 15
Porto Alegre 15
Stockholm 15
Sydney 15
Thái Bình 15
Cairo 14
Curitiba 14
Dhaka 14
Hải Dương 14
Kingston 14
Central 13
Dublin 13
Turin 13
Ankara 12
Biên Hòa 12
Manila 12
Addis Ababa 11
Bangkok 11
Belo Horizonte 11
Campinas 11
Catania 11
Glasgow 11
Hyderabad 11
Medellín 11
Ninh Bình 11
Pittsburgh 11
Totale 17.261
Salva come PNG Salva come JPEG
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 443
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 342
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 338
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 322
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 317
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 309
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 263
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 257
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 254
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 246
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 244
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 242
Effect of hypothermia on human colonic smooth muscle contractility 241
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 240
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 235
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 232
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 232
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 232
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 224
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 223
Disclosing 3D Shape of Ossa Genitalia in Primates 222
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 221
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 221
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 220
Diagnosis of labour: the II prospective clinical study 219
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 217
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 216
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 216
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 215
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 215
Does HE4 have a role in the recurrence of ovarian cancer? 214
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 213
Assessment of liver function by the exhaled breath-print during chronic liver disease 210
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 210
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 209
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 209
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 205
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 198
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 196
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 195
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 194
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 191
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 190
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 185
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 181
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 170
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 157
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 154
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 153
Abruptio placenta and TLRs 2-3-4 151
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 150
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 147
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 146
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 145
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 144
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 142
Alimentazione e gravidanza fisiologica 141
GH-resistance in different stages of chronic liver disease 140
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 139
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 135
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 134
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 133
A meta-synthesis of experiences of caregivers of people with COPD. 131
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 131
Biological effects of cabozantinib on bone microenvironment 130
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 129
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 129
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 128
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 128
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 128
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 126
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 126
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 126
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 126
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 125
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 125
Fetal head-symphysis distance: a simple and reliable ultrasound parameter for the intrapartum assessment of the fetal head descent 124
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 124
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 123
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 123
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 123
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 122
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 120
Baccalaureate nursing students’ attitudes towards old people 120
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 120
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 120
How long is the latent phase of labour? 119
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 119
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 117
Integrated treatment of pancreatic head carcinoma 117
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 117
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 116
ALT levels are associated with metabolic parameters and age in a large real-life population. 116
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 115
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 114
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 111
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 109
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 108
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 108
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 107
Totale 17.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 11 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/202614.752 1.366 507 1.119 1.671 536 1.026 4.469 725 998 1.110 676 549
2026/20272.244 162 1.370 712 0 0 0 0 0 0 0 0 0
Totale 35.355